CDKN2B-AS1 and gastric cancer: Additionally, ANRIL has been found to epigenetically silence miR-99a and miR-449a via PcG complexes, promoting the CDK6/E2F1 pathway and establishing a positive feedback loop for its own expression, continuing, therefore, to promote gastric cancer cell proliferation [98].